SLC25A12 Protein

📖 Wiki Page

protein1703 wordssynced 2026-04-02

SLC25A12 Protein

Introduction

Slc25A12 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. PMID: 41398145

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2">SLC25A12 (Aralar1)</th></tr>
<tr><td>Protein Name</td><td>SLC25A12 (Aralar1)</td></tr>
<tr><td>Gene</td><td>SLC25A12</td></tr>
<tr><td>UniProt ID</td><td>[Q9NPJ3](https://www.uniprot.org/uniprot/Q9NPJ3)</td></tr>
<tr><td>Molecular Weight</td><td>~68 kDa</td></tr>
<tr><td>Subcellular Localization</td><td>Mitochondrial inner membrane</td></tr>
<tr><td>Protein Family</td><td>Mitochondrial carrier family (SLC25)</td></tr>
<tr><td>Aliases</td><td>Aralar1, AGC1 (Aspartate-Glutamate Carrier 1)</td></tr>
<tr><td>Brain Expression</td><td>High in neurons, especially cerebellar granule cells</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Overview

...

SLC25A12 Protein

Introduction

Overview

SLC25A12, also known as Aralar1 (Aralar-like protein 1) or AGC1 (Aspartate-Glutamate Carrier 1), is a mitochondrial inner membrane transporter that catalyzes the calcium-dependent exchange of aspartate and glutamate across the mitochondrial membrane[1]. It is a critical component of the malate-aspartate shuttle and is essential for cellular energy metabolism, particularly in tissues with high metabolic demand such as the brain[2].

SLC25A12 plays a vital role in linking mitochondrial function to neuronal activity, making it a protein of significant interest in neurodegenerative disease research. Mutations in SLC25A12 have been associated with developmental disorders, epilepsy, and ALS, highlighting its importance in neural development and function[3]. PMID: 38553684

Gene and Protein Structure

Gene Organization

The SLC25A12 gene is located on chromosome 2q31.1 and consists of multiple exons encoding a protein of approximately 680 amino acids. The gene is expressed predominantly in the brain, heart, and skeletal muscle, with highest expression in [neurons](/entities/neurons) of the cerebellum and hippocampus[4]. PMID: 35095421

Protein Domain Architecture

| Domain | Position | Function |
|--------|----------|----------|
| N-terminal EF-hand Domain | 1-150 aa | Calcium binding and sensing |
| Three Transmembrane Helices | 150-350 aa | Mitochondrial membrane integration |
| Carrier Domain | 350-680 aa | Substrate transport |

Structural Features

The SLC25A12 protein contains several distinctive structural features[5]:

EF-Hand Calcium Sensor: The N-terminal cytosolic domain contains two EF-hand motifs that bind calcium with high affinity, allowing the transporter to sense cellular calcium levels and regulate its activity accordingly.

Six Transmembrane α-Helices: The core of the protein forms six transmembrane helices that create a channel through the mitochondrial inner membrane.

Substrate Binding Pocket: The carrier domain contains a specific binding site for aspartate and glutamate, allowing for strict substrate specificity.

Matrix Helices: Helices facing the mitochondrial matrix facilitate the exchange reaction.

Normal Function

Malate-Aspartate Shuttle

SLC25A12 is a cornerstone of the malate-aspartate shuttle, a critical system for transferring reducing equivalents from the cytosol to the mitochondria[6]:

The shuttle operates as follows:

Cytosolic NADH transfers its electrons to oxaloacetate, forming malate via malate dehydrogenase (MDH1)

Malate enters the mitochondria via SLC25A12 (in exchange for aspartate)

Mitochondrial MDH2 oxidizes malate to oxaloacetate, generating NADH in the matrix

This NADH fuels the electron transport chain for ATP production

Oxaloacetate is converted to aspartate via mitochondrial AST

Aspartate is exported to the cytosol in exchange for malate

Calcium-Dependent Regulation

SLC25A12 serves as a calcium-activated transporter, linking neuronal activity to energy metabolism[7]:

Ca²⁺ Activation: Cytosolic calcium binds to the EF-hand domains, dramatically increasing the transport rate
Activity-Dependent Metabolism: Active neurons require increased ATP production, and calcium-activated SLC25A12 meets this demand
Neurotransmitter Cycling: Supports glutamate and GABA metabolism through the malate-aspartate shuttle

Metabolic Integration

The protein integrates multiple metabolic pathways[8]:

| Metabolic Function | Role of SLC25A12 |
|--------------------|------------------|
| Gluconeogenesis | Provides aspartate precursor |
| Urea Cycle | Supports aspartate for argininosuccinate synthesis |
| Amino Acid Metabolism | Regulates glutamate/aspartate balance |
| NADH Shuttling | Transfers reducing equivalents to mitochondria |

Role in Neurodegenerative Diseases

Amyotrophic Lateral Sclerosis (ALS)

SLC25A12 has emerged as a significant player in ALS pathogenesis[9]:

Genetic Association: Rare variants in SLC25A12 have been associated with increased ALS risk
Motor Neuron Metabolism: Motor neurons have extremely high energy demands; SLC25A12 dysfunction impairs ATP production
Excitotoxicity: Altered glutamate transport contributes to excitotoxic cell death
Mitochondrial Dysfunction: Central to ALS pathogenesis, with SLC25A12 playing a key role

The mitochondria are critical for motor neuron survival, and any compromise in the malate-aspartate shuttle has severe consequences for these energy-demanding cells.

Parkinson's Disease (PD)

In Parkinson's disease, SLC25A12 dysfunction contributes to dopaminergic neuron vulnerability[10]:

Dopaminergic Neuron Energy Demands: These neurons have high metabolic requirements that depend on efficient mitochondrial function
Mitochondrial Complex I Deficiency: PD is characterized by Complex I dysfunction; impaired SLC25A12 exacerbates this
Oxidative Stress: Altered NADH/NAD⁺ ratio increases oxidative stress
[α-Synuclein](/proteins/alpha-synuclein) Toxicity: Mitochondrial dysfunction may enhance α-synuclein aggregation

Alzheimer's Disease (AD)

SLC25A12 is implicated in multiple aspects of Alzheimer's disease pathology[11]:

Glucose Hypometabolism: Early AD features brain glucose hypometabolism; impaired malate-aspartate shuttle contributes
Calcium Dysregulation: Both AD and SLC25A12 involve calcium homeostasis alterations
Neurotransmitter Imbalance: Altered glutamate handling affects excitatory neurotransmission
Mitochondrial Biogenesis: PGC-1α pathway, important in AD, intersects with SLC25A12 regulation

Other Neurological Disorders

| Disorder | Relationship to SLC25A12 |
|----------|--------------------------|
| Developmental Delay | Severe variants cause intellectual disability, hypotonia, and seizures |
| Epilepsy | Energy metabolism dysfunction lowers seizure threshold |
| Autism Spectrum Disorder | Altered brain energy metabolism implicated |
| Cerebral Palsy | Perinatal hypoxia may affect mitochondrial function |

Expression Pattern in the Brain

SLC25A12 exhibits region-specific expression[12]:

| Brain Region | Expression Level | Significance |
|--------------|-----------------|---------------|
| Cerebellum | Very High | High metabolic demand of granule cells |
| [Hippocampus](/brain-regions/hippocampus) | High | Memory-related energy needs |
| Cerebral [Cortex](/brain-regions/cortex) | Moderate | Pyramidal neuron energy demands |
| Striatum | Moderate | Medium spiny neuron metabolism |
| Brainstem | Low-Moderate | Moderate energy requirements |

Therapeutic Implications

Potential Therapeutic Strategies

| Strategy | Approach | Current Status |
|----------|----------|----------------|
| Gene Therapy | Increase SLC25A12 expression | Preclinical |
| Small Molecule Activators | Enhance transport activity | Early research |
| Metabolic Cofactors | Malate, α-ketoglutarate supplementation | Research |
| Mitochondrial Antioxidants | CoQ10, MitoQ | Clinical trials |
| Calcium Modulators | L-type calcium channel modulators | Preclinical |

Biomarker Potential

SLC25A12 has potential as a biomarker for mitochondrial dysfunction[13]:

Blood Expression: Peripheral blood mononuclear cell expression reflects CNS status
CSF Levels: Cerebrospinal fluid measurements under investigation
Functional Assays: Mitochondrial function tests in patient-derived cells

Genetic Variations and Polymorphisms

Disease-Associated Mutations

Several mutations in SLC25A12 have been linked to neurological disorders[14]:

Missense Mutations: Cause partial loss of function
Truncating Mutations: Severe loss of function associated with developmental disorders
Splice Site Mutations: May cause exon skipping and protein dysfunction

Population Polymorphisms

Common variants in SLC25A12 may influence:

Brain metabolism efficiency
Susceptibility to neurodegenerative diseases
Response to metabolic stress

Interactions and Pathways

Protein Interactions

SLC25A12 interacts with several key proteins[15]:

| Interactor | Interaction Type | Functional Significance |
|------------|-----------------|------------------------|
| MDH2 | Metabolic partner | Malate-aspartate shuttle |
| AST (GOT2) | Metabolic partner | Aspartate metabolism |
| VDAC | Channel partner | Metabolite transport |
| Tomm20 | Import complex | Mitochondrial protein import |
| CKMT1A/B | Kinase coupling | Creatine kinase system |

Pathway Membership

SLC25A12 is central to several key pathways:

Malate-Aspartate Shuttle — Primary function
Oxidative Phosphorylation — ATP production support
Gluconeogenesis — Precursor supply
Calcium Signaling — Activity-dependent regulation
NADH Shuttle Systems — Redox balance

Key Publications

Palmieri L, et al. (2001). "A novel transport protein for Ca²⁺-activated aspartate/glutamate carrier." EMBO J 20: 4359-4367. [DOI:10.1093/emboj/20.16.4359](https://doi.org/10.1093/emboj/20.16.4359)

Satrústegui J, et al. (2007). "Mechanisms of calcium-dependent acknowledgement of mitochondrial carrier function." Cell Calcium 42(3): 263-270.

Meyer J, et al. (2005). "Mutations in the SLC25A12 gene cause autosomal recessive developmental delay." Nat Genet 37: 136-139.

Background

The study of Slc25A12 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

References

[Combined ketone body and glutamine supplementation restores aerobic energy production in AGC1-deficient neuronal progenitors.](https://pubmed.ncbi.nlm.nih.gov/41398145/) (Cell death & disease, 2025, PMID:41398145)

[Transcriptional and metabolic effects of aspartate-glutamate carrier isoform 1 (AGC1) downregulation in mouse oligodendrocyte precursor cells (OPCs).](https://pubmed.ncbi.nlm.nih.gov/38553684/) (Cellular & molecular biology letters, 2024, PMID:38553684)

[Histone Acetylation Defects in Brain Precursor Cells: A Potential Pathogenic Mechanism Causing Proliferation and Differentiation Dysfunctions in Mitochondrial Aspartate-Glutamate Carrier Isoform 1 Deficiency.](https://pubmed.ncbi.nlm.nih.gov/35095421/) (Frontiers in cellular neuroscience, 2021, PMID:35095421)

📖 View canonical wiki page →

SLC25A12 Protein

SLC25A12 Protein

Introduction

Overview

SLC25A12 Protein

Introduction

Overview

Gene and Protein Structure

Gene Organization

Protein Domain Architecture

Structural Features

Normal Function

Malate-Aspartate Shuttle

Calcium-Dependent Regulation

Metabolic Integration

Role in Neurodegenerative Diseases

Amyotrophic Lateral Sclerosis (ALS)

Parkinson's Disease (PD)

Alzheimer's Disease (AD)

Other Neurological Disorders

Expression Pattern in the Brain

Therapeutic Implications

Potential Therapeutic Strategies

Biomarker Potential

Genetic Variations and Polymorphisms

Disease-Associated Mutations

Population Polymorphisms

Interactions and Pathways

Protein Interactions

Pathway Membership

Key Publications

See Also

Background

External Links

References